Cargando…
Hemodiafiltration improves red blood cell lifespan in patients with end‐stage renal disease
INTRODUCTION: Uremic toxin‐induced shortening of red blood cell (RBC) lifespan is an important mechanism of anemia in end‐stage renal disease (ESRD). Conventional hemodialysis does not improve RBC lifespan; the efficacy of hemodiafiltration (HDF) for alleviating RBC lifespan has not yet been evaluat...
Autores principales: | Jiang, Ying, Li, Jiu‐Hong, Luo, Jun‐Feng, Han, Quan‐Sheng, Zhu, Sheng‐Lang, Ma, Yong‐Jian, Zhang, Hou‐De |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298377/ https://www.ncbi.nlm.nih.gov/pubmed/34734675 http://dx.doi.org/10.1111/sdi.13037 |
Ejemplares similares
-
The impact of hemodiafiltration on cognitive function in patients with end-stage renal disease
por: Wang, Xiaoyan, et al.
Publicado: (2023) -
The effect of on-line hemodiafiltration on heart rate variability in end-stage renal disease
por: Park, Kyung Won, et al.
Publicado: (2013) -
Use of Hypertonic Continuous Venovenous Hemodiafiltration to Control Intracranial Hypertension in an End-Stage Renal Disease Patient
por: Rifkin, Stephen I., et al.
Publicado: (2010) -
RBP4: A Culprit for Insulin Resistance in End Stage Renal Disease That Can Be Cleared by Hemodiafiltration
por: Grosjean, Fabrizio, et al.
Publicado: (2017) -
Online hemodiafiltration and mortality risk in end-stage renal disease patients: A critical appraisal of current evidence
por: Schiffl, Helmut
Publicado: (2019)